Benzinga

Benzinga

Benzinga

martes, septiembre 01

Alnylam Pharmaceuticals Inc

ALNYNASDAQ
Trade with Public
Trade with Public
$238.96
-1.73-0.72%
Últ. Act.: Sep 1, 12:16 PM
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Alnylam Pharmaceuticals Financials

Alnylam Pharmaceuticals (ALNY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks

Alnylam cut its 2026 sales outlook despite a Q2 earnings beat as slower ATTR-CM market growth weighed on expectations and investors reacted.
Vandana Singh

PRO
Alnylam Pharmaceuticals Lowers FY2026 Sales Guidance from $5.300B-$5.800B to $5.275B-$5.725B vs $5.580B Est

Alnylam Pharmaceuticals (NASDAQ:ALNY) lowers FY2026 sales outlook from $5.300 billion-$5.800 billion to $5.275 billion-$5.725 billion vs $5.580 billion estimate.
Benzinga Newsdesk

PRO
Alnylam Pharmaceuticals Q2 Adj. EPS $1.84 Beats $1.55 Estimate, Sales $1.291B Miss $1.323B Estimate

Alnylam Pharmaceuticals (NASDAQ:ALNY) reported quarterly earnings of $1.84 per share which beat the analyst consensus estimate of $1.55 by 18.71 percent. This is a 475 percent increase over earnings of $0.32 per share
Benzinga Newsdesk

PRO
Alnylam Pharmaceuticals Affirms FY2026 Sales Guidance of $5.300B-$5.800B vs $5.545B Est

Alnylam Pharmaceuticals (NASDAQ:ALNY) affirms FY2026 sales outlook from $5.300 billion-$5.800 billion to $5.300 billion-$5.800 billion vs $5.545 billion estimate.
Benzinga Newsdesk

PRO
Alnylam Pharmaceuticals Q1 Adj. EPS $1.99 Beats $0.93 Estimate, Sales $1.167B Beat $1.114B Estimate

Alnylam Pharmaceuticals (NASDAQ:ALNY) reported quarterly earnings of $1.99 per share which beat the analyst consensus estimate of $0.93 by 113.98 percent. This is a 586.21 percent increase over earnings of $0.29 per
Benzinga Newsdesk

Earnings Scheduled For April 30, 2026

Benzinga Insights

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved